Introduction: The optimal timing and modality of therapeutic intervention during early phases of HIV infection is still debated; in our prospective observational study we evaluated immunological and virological outcome in HIV' patients treated during acute or recent HIV infection. Figure 1 ) and detected an inverse correlation with CD4 levels at BL (r 0(0.517; p00.008) and a direct correlation with the status of acute infection (r 00.234, p NS). This last correlation reached statistical significance at 12 months (r 00.418, p00.035), whereas the inverse correlation with CD4 levels at BL was still present without a statistical significance (r 0(0.350; p 00.072). Patients treated with three or four drugs did not show any significant difference in immunological nor virological response (Mann-Whitney and x 2 test). Modification or interruption of therapy for tolerability took place in 4 out of 25 patients, all while receiving four drugs; two patients underwent STI between 12 and 18 months following virological success. Conclusions: Treatment of primary infection appeared to be effective in preserving the pool of CD4 cells in acute more than recent infection. There was no evidence of a different outcome through the addition of a fourth drug to the standard treatment. 
